1. Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy
   Martina Caiazza et al, 2020, Genes CrossRef
2. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective
   Mohamed M. Bekhite et al, 2021, Cells CrossRef
3. Proteomic profiling of sudden cardiac death with acquired cardiac hypertrophy
   Yu Kakimoto et al, 2023, International Journal of Legal Medicine CrossRef
4. Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review
   Siobhan Simpson et al, 2017, Veterinary Sciences CrossRef
5. Myocardial contractile proteins
   Asim K. Duttaroy et al, 2024, Cellular, Molecular, and Environmental Contribution in Cardiac Remodeling CrossRef
6. Role of risk stratification and genetics in sudden cardiac death
   Vikrant Rai et al, 2017, Canadian Journal of Physiology and Pharmacology CrossRef
7. Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing
   Yue Zhao et al, 2017, International Journal of Molecular Medicine CrossRef
8. When Paying Attention Pays Back: Missense Mutation c.1006G>A p. (Val336Ile) in PRKAG2 Gene Causing Left Ventricular Hypertrophy and Conduction Abnormalities in a Caucasian Patient: Case Report and Literature Review
   Emanuele Micaglio et al, 2024, International Journal of Molecular Sciences CrossRef
9. Pathogenicity of the Homoplasmic m.8701A>G Variant Requires Confirmation
   Josef Finsterer et al, 2016, Chinese Medical Journal CrossRef
10. Massive Parallel DNA Sequencing of Patients with Inherited Cardiomyopathies in Cyprus and Suggestion of Digenic or Oligogenic Inheritance
    Constantina Koutsofti et al, 2024, Genes CrossRef
11. Next Generation Sequencing Technologies
    R. Rajesh Singh, 2017, Comprehensive Medicinal Chemistry III CrossRef